ArticleBMC cancer2016

Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.

Markus K Schuler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.